Mar. 12, 2022

Molecules of the Month - February 2022

ASP5878

oral FGFR inhibitor Ph. I candidate for solid tumors opt. from previously disclosed lead Bioorg. Med. Chem. Astellas Pharma Inc.

twitterlinkedinprintemail